首页> 美国政府科技报告 >Radiolabelled D2 Agonists as Prolactinoma Imaging Agents: Progress Report for Period February 1, 1988-January 31, 1989.
【24h】

Radiolabelled D2 Agonists as Prolactinoma Imaging Agents: Progress Report for Period February 1, 1988-January 31, 1989.

机译:放射性标记D2激动剂作为催乳素瘤成像剂:1988年2月1日至1989年1月31日期间的进展报告。

获取原文

摘要

Targeted studies completed include the evaluation of tritiated N-0437, evaluation of 35 S-cysteamine, evaluation of 18 F-FDG and initiation of synthetic efforts towards the synthesis of iodinated N-0437 and pergolide analogs. The direction of the project has been changed due to several factors which include the decided lack of favorable experimental results, the excellence of results using muscarinic receptor ligands in pituitary, brain and heart and the contention of the DOE review panel that the original grant proposal was based on flawed assumptions together with their perceived lack of importance to pituitary imaging. In the final year of this grant, three studies will be completed. The first study is the continuation of synthetic efforts to prepare iodinated N-0437 and pergolide analogs for possible use as brain imaging agents. The second study is directed towards completion of biochemical evaluation of various muscarinic receptor analogs for heart, brain and (possible) pituitary imaging. The third study is to probe the use of quaternized D2 receptor ligands for imaging peripheral dopaminergic receptors (including the pituitary). 14 refs., 1 fig., 7 tabs. (ERA citation 14:001876)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号